Healthleap secures $38m to expand AI hospital record screening platform
Healthleap has raised $38 million to expand an AI platform that reviews hospital records and flags patients who may have illnesses that have not been identified. The tool is designed to help care teams decide who needs closer review; it does not diagnose patients.
The funding comprises an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. Founded in South Africa in 2022, Healthleap says its system is used in more than 50 hospitals, including Penn Medicine and Cedars-Sinai, and screens for conditions such as malnutrition and delirium. It combines clinicians’ notes with data such as lab results and vital signs; research cited in the article estimates that 20% to 50% of hospital inpatients are malnourished.
- Healthleap raised $38 million across seed and Series A rounds.
- Its AI flags hospital patients for additional clinical review.
- The platform is deployed in more than 50 hospitals.
New here? Start with this
Hospitals treat thousands of patients, but clinical teams can overlook illnesses, particularly conditions that develop gradually or cause subtle symptoms. Healthleap has created a computer system that reviews patient records, combining clinician notes with lab results and vital signs, then alerts care teams to patients who might have an unrecognised illness needing closer investigation.
The company was founded in South Africa in 2022 and now operates in more than 50 hospitals worldwide, including Penn Medicine and Cedars-Sinai in the United States. It screens for conditions such as malnutrition and delirium, which are common in hospital settings but can be overlooked.
Research indicates that between one-fifth and one-half of hospitalised patients are malnourished, suggesting that such conditions often go unidentified in hospital settings. The system is designed to help care teams prioritise which patients need more thorough review, rather than to diagnose them itself.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Hospitals face persistent problems with undiagnosed conditions—research suggests 20 to 50 per cent of inpatients may be malnourished yet go undetected by clinical staff. An AI system that systematically reviews all patient records against multiple data points can catch patterns that busy clinicians inevitably miss. Since the tool flags patients for closer review rather than issuing diagnoses, it preserves clinical judgment whilst reducing dangerous oversight. Major institutions' adoption suggests meaningful validation of its utility in improving patient safety.
The case against
Introducing AI screening into clinical workflows raises legitimate concerns about automation bias, where physicians may defer to algorithmic recommendations at the expense of their own judgment. Questions remain about false positive rates, which could trigger unnecessary interventions and costs. Algorithmic systems often perform unevenly across different patient populations, raising fairness concerns. Adequate real-world validation of accuracy and unintended consequences should precede widespread adoption, and we should remain cautious about systematically replacing human clinical vigilance with algorithmic oversight in something as critical as patient safety.
AI Entertainment Health Medicine Technology TV
Read the full article at the source →
Originally published by TechCrunch as “Healthleap raises $38M for its AI that flags hospital patients who may need a closer look”.